Nanobac Pharmaceuticals to merge with Eureka Genomics - MarketLine Financial Deals

Nanobac Pharmaceuticals to merge with Eureka Genomics

Nanobac Pharmaceuticals to merge with Eureka Genomics - MarketLine Financial Deals
Nanobac Pharmaceuticals to merge with Eureka Genomics
Published Mar 17, 2009
2 pages — Published Mar 17, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Nanobac Pharmaceuticals, Inc., a company engaged in the discovery and development of products and services to improve human health through the detection and treatment of calcifying nanoparticles, has signed a memorandum of understanding with Eureka Genomics, Inc. (EG), a provider of functional genomics and bioinformatics solutions, under which Nanobac proposes to merge with Eureka in a stock and cash transaction.

  
Source:
Document ID
MA02502_090319
Country
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Nanobac Pharmaceuticals to merge with Eureka Genomics" Mar 17, 2009. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nanobac-Pharmaceuticals-to-merge-with-Eureka-Genomics-2052-2404>
  
APA:
MarketLine Financial Deals. (2009). Nanobac Pharmaceuticals to merge with Eureka Genomics Mar 17, 2009. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Nanobac-Pharmaceuticals-to-merge-with-Eureka-Genomics-2052-2404>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.